Basit öğe kaydını göster

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha 2b: relation to response and HBV genotype

dc.contributor.authorMach, Tomasz
dc.contributor.authorBoucher, Charles A. B.
dc.contributor.authorHansen, Bettina E.
dc.contributor.authorZeuzem, Stefan
dc.contributor.authorJanssen, Harry L. A.
dc.contributor.authorCakaloglu, Yilmaz
dc.contributor.authorTabak, Fehmi
dc.contributor.authorSonneveld, Milan J.
dc.contributor.authorRijckborst, Vincent
dc.contributor.authorSimon, Krzysztof
dc.contributor.authorHeathcote, E. Jenny
dc.date.accessioned2021-03-03T08:44:35Z
dc.date.available2021-03-03T08:44:35Z
dc.date.issued2012
dc.identifier.citationSonneveld M. J. , Rijckborst V., Cakaloglu Y., Simon K., Heathcote E. J. , Tabak F., Mach T., Boucher C. A. B. , Hansen B. E. , Zeuzem S., et al., "Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha 2b: relation to response and HBV genotype", ANTIVIRAL THERAPY, cilt.17, sa.1, ss.9-17, 2012
dc.identifier.issn1359-6535
dc.identifier.othervv_1032021
dc.identifier.otherav_19410923-bc51-4b0f-9c2e-d94723452a30
dc.identifier.urihttp://hdl.handle.net/20.500.12627/22267
dc.identifier.urihttps://doi.org/10.3851/imp1887
dc.description.abstractBackground: On-treatment decline of serum hepatitis B surface antigen (HBsAg) may reflect the immunomodulatory effect of pegylated interferon (PEG-IFN) for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB). We compared HBsAg decline across HBV genotypes between combined responders (HBeAg loss and HBV DNA 10,000 copies/ml) and non-responders.
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectVİROLOJİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectMikrobiyoloji ve Klinik Mikrobiyoloji
dc.subjectViroloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.titleDurable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha 2b: relation to response and HBV genotype
dc.typeMakale
dc.relation.journalANTIVIRAL THERAPY
dc.contributor.departmentErasmus University Rotterdam , ,
dc.identifier.volume17
dc.identifier.issue1
dc.identifier.startpage9
dc.identifier.endpage17
dc.contributor.firstauthorID40875


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster